Last reviewed · How we verify
NCT03050983: IPI
Determination of the Clinical Impact of Continuous Surveillance Monitoring (SM) and Utility of IPI.
trial testing IPI in Respiratory Depression in 440 participants. Completed in 10 September 2020.
26 January 2018
Quick facts
| Lead sponsor | Medtronic - MITG |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 440 |
| Start date | 15 February 2017 |
| Primary completion | 26 January 2018 |
| Estimated completion | 10 September 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- IPI
Conditions studied
- Respiratory Depression — all drugs for Respiratory Depression →
- Respiratory Insufficiency — all drugs for Respiratory Insufficiency →
Sponsor
Medtronic - MITG — full company profile →
Who can join
18 and older, any sex, with Respiratory Depression or Respiratory Insufficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Single site prospective observational nested study of bedside CS20p monitor on the GCF impeded into a retrospective review of the frequency of escalation of care with intermittent vitals signs compared to continuous respiratory monitoring.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prospective randomised trial of the Integrated Pulmonary Index™ in low-acuity inpatients.
Freundlich RE, Walco JP, Mueller DM, Wanderer JP, et al · · 2018 · cited 2× · PMID 30442270 · DOI 10.1016/j.bja.2018.08.019
Verify or expand the search:
- PubMed search for NCT03050983
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Respiratory Depression
Currently open trials in the same condition.
- NCT07166614 — Dexmedetomidine vs Propofol in High-Risk ERCP Patients · NA · recruiting
- NCT06967259 — ENA-001 for Opioid Induced Respiratory Depression · Phase 1 · active not recruiting
- NCT06823661 — Transcutaneous Electrical Stimulation for Apnea Detected by Capnography · NA · recruiting
- NCT06777758 — Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments · Phase 4 · recruiting
- NCT06772961 — Effect of Percutaneous Electrical Acupoint Stimulation on the Improvement of Incidence of Adverse Respiratory Events · NA · recruiting
Other Medtronic - MITG trials
Trials by the same sponsor.
- NCT07351071 — Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Res · NA · recruiting
- NCT07166341 — Accuracy Verification of the INVOS PM7100 · active not recruiting
- NCT07201961 — Nellcor™ Abbreviated Sensor Additional Data Collection · completed
- NCT06710795 — AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair · NA · active not recruiting
- NCT06638073 — Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Department o · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03050983 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medtronic - MITG
- Last refreshed: 30 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03050983.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing